Improvement Efficacy of Influenza Nanovaccine in Combination with Hemokinin-1 Molecular Adjuvant

BACKGROUND: H9N2 avian influenza viruses have the potential to become the next human pandemic threat and next generation vaccine technologies are needed. Current studies introduce nanoparticles as a proper vaccine delivery vehicle for induction of protective immunity. In this study, the efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehghan, Atefeh, Shahsavandi, Shahla, Jabalameli, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252024/
https://www.ncbi.nlm.nih.gov/pubmed/30555652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252024/
https://www.ncbi.nlm.nih.gov/pubmed/30555652

Ejemplares similares